# Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

> **NCT00963157** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 789 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** AS03
- **BIOLOGICAL:** Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A

## Key facts

- **NCT ID:** NCT00963157
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 789 (ACTUAL)
- **Last updated:** 2014-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00963157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00963157, "Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00963157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*